Aberrant regulation of CXCR4 in cancer via deviant microRNA-targeted interactions

Alexei J Stuckel1, Tripti Khare1, Marc Bissonnette2

  • 1Department of Medicine, Division of Gastroenterology and Hepatology, University of Missouri, Columbia, Missouri 65212, USA.

Epigenetics
|September 1, 2022
PubMed

Insights

Aberrant microRNA (miRNA) interactions with CXCR4 are key in cancer metastasis. This review details these interactions, highlighting their role in cancer progression and potential therapeutic strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • CXCR4 plays a critical role in cancer metastasis through its deregulation.
  • Aberrant microRNA (miRNA)-CXCR4 interactions are significant contributors to cancer development.
  • MicroRNAs regulate gene expression by targeting messenger RNA (mRNA) 3' untranslated regions (UTRs).

Approach:

  • This review characterizes aberrant miRNA-CXCR4 interactions across various human cancers.
  • It identifies specific miRNA binding sites on the CXCR4 3' UTR and their regulatory effects.
  • The study examines downstream pathways, prognostic significance of miRNAs, and the role of oncomirs.

Key Points:

  • Tumor suppressor miRNAs binding to CXCR4's 3' UTR regulate its expression.
  • Deregulation of both tumor suppressor miRNAs and oncomirs impacts CXCR4 expression.
  • The miR-146a-CXCR4 axis is implicated in virus-associated cancers.

Conclusions:

  • Understanding miRNA-CXCR4 interactions is crucial for cancer research.
  • Dysregulated miRNA-CXCR4 interactions offer potential therapeutic targets.
  • miRNA-based therapies and CXCR4 antagonists represent future treatment avenues.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.3K